Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and Adults Aged 10 to 55 Years
Phase of Trial: Phase III
Latest Information Update: 05 Jul 2017
At a glance
- Drugs Meningococcal vaccine groups A C Y W-135 conjugate (Primary)
- Indications Meningococcal group A infections; Meningococcal group C infections; Meningococcal group W-135 infections; Meningococcal group Y infections; Meningococcal meningitis
- Focus Pharmacodynamics; Registrational
- Sponsors sanofi pasteur
- 28 Jun 2017 Status changed from active, no longer recruiting to completed.
- 17 Aug 2016 Status changed from recruiting to active, no longer recruiting.
- 27 Jul 2016 New trial record